News

Royal Philips announced a collaboration with Epic to integrate Philips’ suite of cardiac ambulatory monitoring and diagnostics services with Aura.

“AF is a powerful risk marker that we need to take into consideration when planning and performing these procedures,” says corresponding author Stamatios Lerakis, MD, PhD. M-TEER was equally successful in both groups (AF and no AF). However,...

"Cutting reimbursements for procedures that reduce strokes, such as the 27% in the proposed rule to transcatheter left atrial appendage occlusion (LAAO), will only increase the risk of hospitalization and long-term disability for vulnerable...

Kardium Inc., the developer of the Globe® Pulsed Field System – an innovative treatment for atrial fibrillation (AF) – has raised US$250 million in a new financing round.

New flow rate guidance designed to optimize irrigation and support consistent procedural outcomes; 10,000+ VARIPULSE global procedures with low adverse event rate reinforces platform’s strong safety profile